This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Bacterial Infections  • Dermatology  • Dermatologic Disorders  • Dermatologic Disorders, Other  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Arch Dermatol. 2004;140:1020-1021.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Rocky Mountain spotted fever (RMSF), a tickborne infection caused by Rickettsia rickettsii and characterized by a rash (Figure 1, has a case-fatality rate as high as 30% in certain untreated patients.¹ Even with treatment, hospitalization rates of 72% and case-fatality rates of 4% have been reported.^1-3 This report summarizes the clinical course of three fatal cases of RMSF in children and related illness in family members during the summer of 2003. These cases underscore the importance of 1) prompt diagnosis and appropriate antimicrobial therapy in patients with RMSF to prevent deaths and 2) consideration of RMSF as a diagnosis in family members and contacts who have febrile illness and share environmental exposures with the patient.

Figure. Child with Rocky Mountain spotted fever has the rash that is characteristic but typically does not appear until several days after fever onset.

Case Reports

Oklahoma. In late May, a female child aged 7 . . . [Full Text of this Article]

Reported by:

Editorial Note:


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?